Mannkind reported $1.05B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adma Biologics ADMA:US $ 0.39B 0.03B
Biocryst Pharmaceuticals BCRX:US $ 1.97B 1.04B
Chemocentryx CCXI:US $ 1.76B 0.02B
Dynavax Technologies DVAX:US $ 1.59B 0.24B
Eli Lilly And LLY:US $ 308.07B 35.35B
Halozyme Therapeutics HALO:US $ 6.07B 0.58B
Immunogen IMGN:US $ 0.99B 0.06B
Insmed INSM:US $ 2.36B 0.43B
Karyopharm Therapeutics KPTI:US $ 0.36B 0.22B
Macrogenics MGNX:US $ 0.18B 0.36B
Mannkind MNKD:US $ 0.96B 0.03B
Merk MRK:US $ 230.55B 23.1B
Minerva Neurosciences NERV:US $ 0.02B 0.02B
Novavax NVAX:US $ 4.02B 1.6B
Novo Nordisk A Fs NVO:US 192.52B 4.99B
Peregrine Pharmaceuticals PPHM:US $ 1.26B 0.54B
Pfizer PFE:US $ 294.18B 1.79B
Sanofi SAN:FP 121.89B 4.99B
Xencor XNCR:US $ 1.63B 0.05B